Exelixis (EXEL) News Today $33.29 -0.39 (-1.16%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Zacks Research Estimates Exelixis' Q4 Earnings (NASDAQ:EXEL)December 21 at 1:38 AM | americanbankingnews.comBMO Capital Downgrades Exelixis (EXEL)December 20 at 9:40 PM | msn.comExelixis downgraded to Market Perform from Outperform at BMO CapitalDecember 20 at 11:38 AM | markets.businessinsider.comBMO Capital Markets Downgrades Exelixis (NASDAQ:EXEL) to Market PerformBMO Capital Markets downgraded shares of Exelixis from an "outperform" rating to a "market perform" rating and raised their target price for the stock from $36.00 to $40.00 in a report on Friday.December 20 at 7:41 AM | marketbeat.comFranklin Resources Inc. Sells 72,798 Shares of Exelixis, Inc. (NASDAQ:EXEL)Franklin Resources Inc. cut its holdings in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 8.4% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 794,643 shares of the biotechnology company's stock after selling 72,798 sharesDecember 20 at 5:08 AM | marketbeat.comEquities Analysts Issue Forecasts for Exelixis Q4 EarningsExelixis, Inc. (NASDAQ:EXEL - Free Report) - Investment analysts at Zacks Research boosted their Q4 2024 earnings per share (EPS) estimates for Exelixis in a note issued to investors on Monday, December 16th. Zacks Research analyst E. Bagri now expects that the biotechnology company will post earDecember 19 at 10:02 AM | marketbeat.comExelixis downgraded to Neutral from Buy at BofADecember 19 at 12:49 AM | markets.businessinsider.comBarclays PLC Sells 102,720 Shares of Exelixis, Inc. (NASDAQ:EXEL)Barclays PLC decreased its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 24.3% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 319,589 shares of the biotechnology company's stock after selling 102,720 shares duDecember 18 at 4:08 AM | marketbeat.comY Intercept Hong Kong Ltd Lowers Position in Exelixis, Inc. (NASDAQ:EXEL)Y Intercept Hong Kong Ltd decreased its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 74.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 13,393 shares of the biotechnology company's stock after selling 38,998 shares during the periDecember 18 at 4:06 AM | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Sees Significant Increase in Short InterestDecember 18 at 3:05 AM | americanbankingnews.comExelixis downgraded to Neutral at BofA following 37% rallyDecember 17, 2024 | markets.businessinsider.comExpert Outlook: Exelixis Through The Eyes Of 19 AnalystsDecember 17, 2024 | benzinga.comB of A Securities Downgrades Exelixis (EXEL)December 17, 2024 | msn.comExelixis cut to neutral from buy by BofADecember 17, 2024 | seekingalpha.comBank of America Downgrades Exelixis (NASDAQ:EXEL) to NeutralBank of America cut Exelixis from a "buy" rating to a "neutral" rating and upped their price target for the company from $35.00 to $39.00 in a research report on Tuesday.December 17, 2024 | marketbeat.comIs Exelixis Positioned to Capitalize on Emerging Cancer Therapies?December 17, 2024 | stocknews.comExelixis, Inc. (NASDAQ:EXEL) Shares Sold by Public Employees Retirement System of OhioPublic Employees Retirement System of Ohio lessened its stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 32.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 113,752 shares of the biotechnology comDecember 17, 2024 | marketbeat.comWellington Management Group LLP Has $6.37 Million Stake in Exelixis, Inc. (NASDAQ:EXEL)Wellington Management Group LLP lowered its position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 33.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 245,342 shares of the biotechnology company's stDecember 17, 2024 | marketbeat.comShort Interest in Exelixis, Inc. (NASDAQ:EXEL) Expands By 5.8%Exelixis, Inc. (NASDAQ:EXEL - Get Free Report) saw a large growth in short interest in November. As of November 30th, there was short interest totalling 8,360,000 shares, a growth of 5.8% from the November 15th total of 7,900,000 shares. Based on an average daily trading volume, of 2,120,000 shares, the days-to-cover ratio is currently 3.9 days. Approximately 3.0% of the shares of the company are short sold.December 16, 2024 | marketbeat.comRetirement Systems of Alabama Purchases 180,021 Shares of Exelixis, Inc. (NASDAQ:EXEL)Retirement Systems of Alabama increased its holdings in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 24.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 911,497 shares of the biotechnology company's stock afteDecember 15, 2024 | marketbeat.comTri Ri Asset Management Corp Buys Shares of 167,069 Exelixis, Inc. (NASDAQ:EXEL)Tri Ri Asset Management Corp acquired a new stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 167,069 shares of the biotechnology company's stock, valued at approximatelyDecember 13, 2024 | marketbeat.comKovitz Investment Group Partners LLC Takes Position in Exelixis, Inc. (NASDAQ:EXEL)Kovitz Investment Group Partners LLC acquired a new stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 17,739 shares of the biotechnology company's sDecember 13, 2024 | marketbeat.comUnsupported price hikes added $815 million to US drug spending in 2023December 12, 2024 | msn.comState Street Corp Sells 1,157,988 Shares of Exelixis, Inc. (NASDAQ:EXEL)State Street Corp lowered its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 9.2% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 11,443,668 shares of the biotechnology company's stock after selling 1,1December 11, 2024 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Given Average Rating of "Moderate Buy" by BrokeragesExelixis, Inc. (NASDAQ:EXEL - Get Free Report) has been given a consensus rating of "Moderate Buy" by the twenty analysts that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issuedDecember 11, 2024 | marketbeat.comVerition Fund Management LLC Invests $1.23 Million in Exelixis, Inc. (NASDAQ:EXEL)Verition Fund Management LLC acquired a new position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 47,195 shares of the biotechnology company's stock,December 8, 2024 | marketbeat.com2 Biotech Stocks to Buy Hand Over Fist in DecemberDecember 7, 2024 | fool.comPoint72 DIFC Ltd Takes Position in Exelixis, Inc. (NASDAQ:EXEL)Point72 DIFC Ltd bought a new position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 17,200 shares of the biotechnology company's stock, valued aDecember 7, 2024 | marketbeat.comFmr LLC Raises Stock Position in Exelixis, Inc. (NASDAQ:EXEL)Fmr LLC grew its position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 6.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,462,072 shares of the biotechnology company's stock after buying an additionDecember 7, 2024 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Shares Acquired by Cerity Partners LLCCerity Partners LLC increased its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 129.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 27,994 shares of the biotechnology company's stock afterDecember 7, 2024 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Decreases Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its holdings in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 6.4% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 810,541 shares oDecember 6, 2024 | marketbeat.comSystematic Financial Management LP Increases Stake in Exelixis, Inc. (NASDAQ:EXEL)Systematic Financial Management LP grew its position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 7.1% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,168,391 shares of the biotechnology company's stock after buying an additiDecember 5, 2024 | marketbeat.comNFJ Investment Group LLC Takes Position in Exelixis, Inc. (NASDAQ:EXEL)NFJ Investment Group LLC purchased a new stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 61,012 shares of the biotechnology company's stock, valued at approximatelDecember 5, 2024 | marketbeat.comPaloma Partners Management Co Acquires New Holdings in Exelixis, Inc. (NASDAQ:EXEL)Paloma Partners Management Co acquired a new stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 18,635 shares of the biotechnology company's stock, valued at approximately $48December 5, 2024 | marketbeat.comBNP Paribas Financial Markets Trims Position in Exelixis, Inc. (NASDAQ:EXEL)BNP Paribas Financial Markets cut its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 19.7% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 131,659 shares of the biotechnology company's stock after selling 32,223 shares during thDecember 5, 2024 | marketbeat.comBank of Montreal Can Acquires 35,496 Shares of Exelixis, Inc. (NASDAQ:EXEL)Bank of Montreal Can lifted its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 51.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 104,385 shares of the biotechnology company's stock after purchasingDecember 5, 2024 | marketbeat.comExelixis' (NASDAQ:EXEL) earnings growth rate lags the 29% CAGR delivered to shareholdersDecember 4, 2024 | finance.yahoo.comJacobs Levy Equity Management Inc. Decreases Stock Position in Exelixis, Inc. (NASDAQ:EXEL)Jacobs Levy Equity Management Inc. decreased its position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 17.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 2,082,283 shares of the biotechnology company's stock after selling 438,900 shares duriDecember 4, 2024 | marketbeat.comErste Asset Management GmbH Buys Shares of 74,500 Exelixis, Inc. (NASDAQ:EXEL)Erste Asset Management GmbH purchased a new stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 74,500 shares of the biotechnology company's stoDecember 4, 2024 | marketbeat.comEdgestream Partners L.P. Sells 41,577 Shares of Exelixis, Inc. (NASDAQ:EXEL)Edgestream Partners L.P. decreased its stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 36.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 73,208 shares of the biotechnology company's stock after selling 41,577 shares during the pDecember 4, 2024 | marketbeat.comExelixis’s Cabozantinib Studies Face Uncertainty and Safety Concerns Leading to Hold RatingDecember 3, 2024 | markets.businessinsider.comExelixis, Inc. (NASDAQ:EXEL) EVP Jeffrey Hessekiel Sells 60,000 SharesDecember 3, 2024 | insidertrades.comExelixis EVP sells $2.2 million in stockDecember 2, 2024 | investing.comPoint72 Asia Singapore Pte. Ltd. Invests $657,000 in Exelixis, Inc. (NASDAQ:EXEL)Point72 Asia Singapore Pte. Ltd. acquired a new position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 25,308 shares of the biotechnology company's stock, valued at approximaDecember 2, 2024 | marketbeat.comPoint72 Hong Kong Ltd Makes New Investment in Exelixis, Inc. (NASDAQ:EXEL)Point72 Hong Kong Ltd bought a new stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 36,918 shares of the biotechnology company's stock, valDecember 2, 2024 | marketbeat.comCaisse DE Depot ET Placement DU Quebec Invests $14.98 Million in Exelixis, Inc. (NASDAQ:EXEL)Caisse DE Depot ET Placement DU Quebec acquired a new stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 577,228 shares of the biotechnology companyDecember 2, 2024 | marketbeat.comBellevue Group AG Lowers Stock Position in Exelixis, Inc. (NASDAQ:EXEL)Bellevue Group AG trimmed its position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 11.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,600,000 shares of the biotechnology company's stock after sellinDecember 1, 2024 | marketbeat.com24,070 Shares in Exelixis, Inc. (NASDAQ:EXEL) Purchased by Capstone Investment Advisors LLCCapstone Investment Advisors LLC purchased a new stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 24,070 shares of the biotechnology company's stock, valued at approximately $62November 30, 2024 | marketbeat.comDynamic Technology Lab Private Ltd Acquires Shares of 22,791 Exelixis, Inc. (NASDAQ:EXEL)Dynamic Technology Lab Private Ltd bought a new position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The fund bought 22,791 shares of the biotechnology company's stock, valued at approximately $591,000. Several otherNovember 29, 2024 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Shares Sold by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. decreased its position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 1.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,273,620 shares ofNovember 28, 2024 | marketbeat.com Get Exelixis News Delivered to You Automatically Sign up to receive the latest news and ratings for EXEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Cackling Kamala hates this company (Ad)Do you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. EXEL Media Mentions By Week EXEL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EXEL News Sentiment▼0.690.60▲Average Medical News Sentiment EXEL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EXEL Articles This Week▼259▲EXEL Articles Average Week Get Exelixis News Delivered to You Automatically Sign up to receive the latest news and ratings for EXEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alnylam Pharmaceuticals News Biogen News United Therapeutics News Neurocrine Biosciences News Incyte News BioMarin Pharmaceutical News Exact Sciences News Repligen News Madrigal Pharmaceuticals News Halozyme Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EXEL) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exelixis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exelixis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EXEL Stock Alerts